144 related articles for article (PubMed ID: 3877403)
1. Autoradiography of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): uptake in the monoaminergic pathways and in melanin containing tissues.
Lydén A; Bondesson U; Larsson BS; Lindquist NG; Olsson LI
Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):130-5. PubMed ID: 3877403
[TBL] [Abstract][Full Text] [Related]
2. Distribution of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in experimental animals studied by postiron emission tomography and whole body autoradiography.
Hartvig P; Lindquist NG; Aquilonius SM; d'Argy R; Bergström K; Bondesson U; Eckernäs SA; Gullberg P; Larsson BS; Lindberg B
Life Sci; 1986 Jan; 38(1):89-97. PubMed ID: 3484535
[TBL] [Abstract][Full Text] [Related]
3. Distribution of 1-(3H)-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (3H-MPTP) in the frog: uptake in neuromelanin.
Sokolowski AL; Larsson BS; Lindquist NG
Pharmacol Toxicol; 1990 Apr; 66(4):252-8. PubMed ID: 2371232
[TBL] [Abstract][Full Text] [Related]
4. Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin.
Lindquist NG; Larsson BS; Lydén-Sokolowski A
Neurosci Lett; 1988 Oct; 93(1):1-6. PubMed ID: 3264893
[TBL] [Abstract][Full Text] [Related]
5. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
Nature; 1987 May 28-Jun 3; 327(6120):324-6. PubMed ID: 2884568
[TBL] [Abstract][Full Text] [Related]
6. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.
D'Amato RJ; Lipman ZP; Snyder SH
Science; 1986 Feb; 231(4741):987-9. PubMed ID: 3080808
[TBL] [Abstract][Full Text] [Related]
7. Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition.
Lydén-Sokolowski A; Larsson BS; Lindquist NG
Pharmacol Toxicol; 1988 Aug; 63(2):75-80. PubMed ID: 3141911
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in mice.
Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
Neurosci Lett; 1985 Jul; 58(1):133-7. PubMed ID: 3876523
[TBL] [Abstract][Full Text] [Related]
9. Neuromelanin: a role in MPTP-induced neurotoxicity.
D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
Life Sci; 1987 Feb; 40(8):705-12. PubMed ID: 2880274
[TBL] [Abstract][Full Text] [Related]
10. Interactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium species with synthetic dopamine-melanin.
Wu EY; Chiba K; Trevor AJ; Castagnoli N
Life Sci; 1986 Nov; 39(18):1695-700. PubMed ID: 3490611
[TBL] [Abstract][Full Text] [Related]
11. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.
Herkenham M; Little MD; Bankiewicz K; Yang SC; Markey SP; Johannessen JN
Neuroscience; 1991; 40(1):133-58. PubMed ID: 2052148
[TBL] [Abstract][Full Text] [Related]
12. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice.
Sundström E; Strömberg I; Tsutsumi T; Olson L; Jonsson G
Brain Res; 1987 Mar; 405(1):26-38. PubMed ID: 2882814
[TBL] [Abstract][Full Text] [Related]
13. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
[TBL] [Abstract][Full Text] [Related]
14. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
Heikkila RE; Hess A; Duvoisin RC
Life Sci; 1985 Jan; 36(3):231-6. PubMed ID: 3917525
[TBL] [Abstract][Full Text] [Related]
16. Similar distribution of monoamine oxidase (MAO) and parkinsonian toxin (MPTP) binding sites in human brain.
Reznikoff G; Manaker S; Parsons B; Rhodes CH; Rainbow TC
Neurology; 1985 Oct; 35(10):1415-9. PubMed ID: 3875804
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.
Heikkila RE; Hess A; Duvoisin RC
Science; 1984 Jun; 224(4656):1451-3. PubMed ID: 6610213
[TBL] [Abstract][Full Text] [Related]
18. Studies on the melanin affinity of haloperidol.
Lydén A; Larsson B; Lindquist NG
Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):230-43. PubMed ID: 7181580
[TBL] [Abstract][Full Text] [Related]
19. Melanin affinity of manganese.
Lydén A; Larsson BS; Lindquist NG
Acta Pharmacol Toxicol (Copenh); 1984 Aug; 55(2):133-8. PubMed ID: 6437141
[TBL] [Abstract][Full Text] [Related]
20. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
